Alzamend Neuro (ALZN) Earnings Date & Reports

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALZN is expected to report earnings to -67 cents per share on September 15

Alzamend Neuro ALZN Stock Earnings Reports

Q3'26

Est.

$-0.67

Q2'26

Missed

by $0.25

Q1'26

Missed

by $0.16

Q4'25

Beat

by $0.31

Q3'25

Missed

by $0.66

The last earnings report on July 01 showed earnings per share of -67 cents, missing the estimate of -41 cents. With 20.26K shares outstanding, the current market capitalization sits at 6.28M.

View a ticker or compare two or three

ALZN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days